GATA2 mutations and overexpression in pediatric acute myeloid leukemia

GATA2 mutations and overexpression in pediatric acute myeloid leukemia

Background: GATA2 is important for the regulation of development and proliferation of early pluripotent hematopoietic precursors, and precise GATA2 expression is critical in myeloid lineage maturation. GATA2 mutations have been reported in acute myeloid leukemia (AML) but only few studies of GATA2 m...

Full description

Bibliographic Details
Main Authors:	Zhenzhen Yang, Xingjuan Wang, Xi Chen, Hu Dou, Yi Huang, Ling Lu, Lin Zou, Junqin Bi, Meng Su, Jie Yu, Liming Bao
Format:	Article
Language:	English
Published:	Elsevier 2019-08-01
Series:	Pediatric Hematology Oncology Journal
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468124519302463

Similar Items

Cytogenetic and mutational analysis and outcome assessment of a cohort of 284 children with de novo acute myeloid leukemia reveal complex karyotype as an adverse risk factor for inferior survival
by: Xi Chen, et al.
Published: (2021-05-01)

GATA1 Mutation In Transient Leukemia (TL) and Myeloid Leukemia of Down Syndrome
by: Reinhardt, K, et al.
Published: (2010)

GATA1 Mutation In Transient Leukemia (TL) and Myeloid Leukemia of Down Syndrome
by: Reinhardt, K, et al.
Published: (2010)

Analysis of GATA1 mutations in Down syndrome transient myeloproliferative disorder and myeloid leukemia.
by: Alford, K, et al.
Published: (2011)

GATA1 mutational analysis in chronic myeloid leukaemia.
by: Halsey, C, et al.
Published: (2007)

Analysis of GATA-1 mutations in chronic myeloid leukaemia.
by: Halsey, C, et al.
Published: (2006)

Overexpression of GATA1 confers resistance to chemotherapy in acute megakaryocytic Leukemia.
by: John Timothy Caldwell, et al.
Published: (2013-01-01)

GATA2 Inhibition Sensitizes Acute Myeloid Leukemia Cells to Chemotherapy.
by: Li Yang, et al.
Published: (2017-01-01)

GATA1 and cooperating mutations in myeloid leukaemia of Down syndrome
by: Garnett, C, et al.
Published: (2019)

GATA2 DEFICIENCY SYNDROME: MDS / ACUTE MYELOID LEUKEMIA IN AN ADOLESCENT PATIENT
by: Sebnem Yilmaz, et al.
Published: (2023-12-01)

Correction: GATA2 Inhibition Sensitizes Acute Myeloid Leukemia Cells to Chemotherapy.
by: Li Yang, et al.
Published: (2017-01-01)

Overexpression of HOXA10 is associated with unfavorable prognosis of acute myeloid leukemia
by: Chao Guo, et al.
Published: (2020-06-01)

Gata2 as a Crucial Regulator of Stem Cells in Adult Hematopoiesis and Acute Myeloid Leukemia
by: Juan Bautista Menendez-Gonzalez, et al.
Published: (2019-08-01)

Aberrant GATA2 Activation in Pediatric B-Cell Acute Lymphoblastic Leukemia
by: Han Wang, et al.
Published: (2022-01-01)

Pediatric chronic myeloid leukemia in myeloid blast crisis
by: Biswajit Dey, et al.
Published: (2023-04-01)

How do Gata1 and cohesin gene mutations contribute to the development of myeloid leukaemia?
by: Garnett, C
Published: (2020)

Mutational Landscape of CEBPA in Mexican Pediatric Acute Myeloid Leukemia Patients: Prognostic Implications
by: Carolina Molina Garay, et al.
Published: (2022-07-01)

Overexpression of annexin A5 might guide the gemtuzumab ozogamicin treatment choice in patients with pediatric acute myeloid leukemia
by: Nan Zhang, et al.
Published: (2020-05-01)

Overexpression of human GATA-1 and GATA-2 interferes with spine formation and produces depressive behavior in rats.
by: Miyeon Choi, et al.
Published: (2014-01-01)

Nrf2 overexpression increases risk of high tumor mutation burden in acute myeloid leukemia by inhibiting MSH2
by: Ping Liu, et al.
Published: (2021-01-01)

TET2 lesions enhance the aggressiveness of CEBPA-mutant acute myeloid leukemia by rebalancing GATA2 expression
by: Elizabeth Heyes, et al.
Published: (2023-10-01)

Myeloid leukemia in children 4 years or older with Down syndrome often lacks GATA1 mutation and cytogenetics and risk of relapse are more akin to sporadic AML.
by: Hasle, H, et al.
Published: (2008)

VARIANT PROFILING IN PEDIATRIC CHRONIC MYELOID LEUKEMIA
by: Yvonne Lisa Behrens, et al.
Published: (2023-12-01)

Pediatric acute myeloid leukemia with breast chloromas
by: Maria S. Gallardo, et al.
Published: (2023-05-01)

NEW ADVANCES IN PEDIATRIC ACUTE MYELOID LEUKEMIA
by: Özlem Tüfekçi
Published: (2021-11-01)

Wilms Tumor 1 Mutations Are Independent Poor Prognostic Factors in Pediatric Acute Myeloid Leukemia
by: Yin Wang, et al.
Published: (2021-04-01)

Abnormalities in the myeloid progenitor compartment in Down syndrome fetal liver precede acquisition of GATA1 mutations.
by: Tunstall-Pedoe, O, et al.
Published: (2008)

Chromatin-Spliceosome Mutations in Acute Myeloid Leukemia
by: Yotaro Ochi, et al.
Published: (2021-03-01)

Nucleophosmin 1 Mutations in Acute Myeloid Leukemia
by: Jabra Zarka, et al.
Published: (2020-06-01)

The detection of KIT mutations in acute myeloid leukemia
by: Luis Eduardo Silva Machado, et al.
Published: (2012-09-01)

Differential Requirement of Gata2a and Gata2b for Primitive and Definitive Myeloid Development in Zebrafish
by: Oscar A. Peña, et al.
Published: (2021-09-01)

Overexpression of lncRNA PANDAR predicts adverse prognosis in acute myeloid leukemia
by: Yang L, et al.
Published: (2018-10-01)

Global proteomics dataset of miR-126 overexpression in acute myeloid leukemia
by: Erwin M. Schoof, et al.
Published: (2016-12-01)

Acute Myeloid Leukemia With CEBPA Mutations: Current Progress and Future Directions
by: Long Su, et al.
Published: (2022-02-01)

Profiling FLT3 Mutations in Mexican Acute Myeloid Leukemia Pediatric Patients: Impact on Overall Survival
by: Carolina Molina Garay, et al.
Published: (2020-09-01)

Acute Promyelocytic Leukemia or Acute Myeloid Leukemia with Mutated NPM1?
by: Maximiliano Cloobs Venezia, et al.
Published: (2022-11-01)

Over-Expressed GATA-1<sub>S</sub>, the Short Isoform of the Hematopoietic Transcriptional Factor GATA-1, Inhibits Ferroptosis in K562 Myeloid Leukemia Cells by Preventing Lipid Peroxidation
by: Silvia Trombetti, et al.
Published: (2023-02-01)

Risk factors affect accurate prognosis in ASXL1-mutated acute myeloid leukemia
by: Yi Fan, et al.
Published: (2021-10-01)

Risk-Stratified Therapy for Pediatric Acute Myeloid Leukemia
by: Daisuke Tomizawa, et al.
Published: (2023-08-01)

Pediatric Acute Myeloid Leukemia—Past, Present, and Future
by: Dirk Reinhardt, et al.
Published: (2022-01-01)